Body weight-adjusted Uptravi (selexipag) dosing for children and adolescents with pulmonary arterial hypertension (PAH) resulted in exposure to…
Articles by Andrea Lobo
The U.S. Food and Drug Administration (FDA) has provided Tiakis Biotech with advice for a planned Phase 2 clinical…
The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to ALG-801, Alivegen’s experimental treatment for…
Blood levels of angiopoietin-2, a marker of blood vessel damage, may help predict treatment response and outcomes in pulmonary…
Indicators of high blood sugar levels, particularly stress hyperglycemia ratio (SHR), may predict clinical worsening in people with idiopathic…
A new educational campaign aims to raise awareness of pulmonary arterial hypertension (PAH) symptoms, with the goal of accelerating…
Abnormalities in blood levels of various microRNAs (miRNAs) — small RNA…
A new device to deliver inhaled nitric oxide gas to newborns with pulmonary hypertension (PH), is now available for…
Exosomes, a type of small vesicle released by mesenchymal stem cells (MSCs), helped reduce vascular remodeling and ease pulmonary…
Liquidia has expanded a license agreement with Pharmosa Biopharm, acquiring rights to market L606, a potential…
The use of selenium supplements — an essential mineral naturally present in many foods and added to others — reduced…
Cereno Scientific’s investigational therapy CS014 was found to reverse remodeling, meaning alterations in structure and arrangement, of pulmonary…